专利信息

首页 1 2 3 下页尾页共 30 条记录, 当前第1/3页。

A orally disintegrating tablet is obtained by tableting fine granules showing controlled release of lansoprazole and an additive which is capable of suppressing breakage of the fine granules during tableting and can control the release of lansoprazole for a long time and can maintain a therapeutically effective concentration for a prolonged time and shows superior disintegration property in the oral cavity.

专利标题：Process for the crystallization of (r)- or (s)-lansoprazole

The present invention relates to a production method of a crystal of (R)-lansoprazole or (S)-lansoprazole which includes crystallization at a temperature of about 0°C to about 35°C from a C1-4 alkyl acetate solution containing (R)-lansoprazole or (S)-lansoprazole at a concentration of about 0.1 g/mL to about 0.5 g/mL and the like. According to the production method of the present invention a crystal of (R)-lansoprazole or (S)-lansoprazole superior in preservation stability can be produced effici...

专利标题：Method for producing lansoprazole

专利标题：Orally disintegrating tablet

专利标题：Process for the crystallization of (r)- or (s)-lansoprazole

专利标题：Orally disintegrating tablet.

Provided is an orally disintegrating tablet obtained by tableting fine granules showing controlled release of lansoprazole and an additive which is capable of suppressing breakage of the fine granules during tableting and can control the release of lansoprazole for a long time and can maintain a therapeutically effective concentration for a prolonged time and shows superior disintegration property in the oral cavity. An orally disintegrating tablet containing (i) fine granules showing controlled...

专利标题：Granules containing lansoprazole in large amount

专利标题：Orally disintegrating tablet

专利标题：Granules containing lansoprazole in large amount

专利标题：Orally disintegrating tablet

当前查询条件: [专利权人] 包含 'TAKEDA PHARMACEUTICAL COMPANY LIMITED' AND [药品] 包含 'Lansoprazole '

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. MA34768B1	2013/12/3	MA20130036063	2013/6/28
专利标题：专利权人：TAKEDA PHARMACEUTICAL COMPANY LIMITED; A orally disintegrating tablet is obtained by tableting fine granules showing controlled release of lansoprazole and an additive which is capable of suppressing breakage of the fine granules during tableting and can control the release of lansoprazole for a long time and can maintain a therapeutically effective concentration for a prolonged time and shows superior disintegration property in the oral cavity.

2. HU229356B1	2013/11/28	HU20040000781	2001/11/30
专利标题：Process for the crystallization of (r)- or (s)-lansoprazole 专利权人：TAKEDA PHARMACEUTICAL COMPANY LIMITED; The present invention relates to a production method of a crystal of (R)-lansoprazole or (S)-lansoprazole which includes crystallization at a temperature of about 0°C to about 35°C from a C1-4 alkyl acetate solution containing (R)-lansoprazole or (S)-lansoprazole at a concentration of about 0.1 g/mL to about 0.5 g/mL and the like. According to the production method of the present invention a crystal of (R)-lansoprazole or (S)-lansoprazole superior in preservation stability can be produced effici...

3. EP2264025B1	2013/11/6	EP20100177460	2005/9/13
专利标题：Method for producing lansoprazole 专利权人：TAKEDA PHARMACEUTICAL COMPANY LIMITED;

4. US20130273157A1	2013/10/17	US13/997862	2011/12/26
专利标题：Orally disintegrating tablet 专利权人：TAKEDA PHARMACEUTICAL COMPANY LIMITED; A orally disintegrating tablet is obtained by tableting fine granules showing controlled release of lansoprazole and an additive which is capable of suppressing breakage of the fine granules during tableting and can control the release of lansoprazole for a long time and can maintain a therapeutically effective concentration for a prolonged time and shows superior disintegration property in the oral cavity.

5. PL214684B1	2013/9/30	PL20010362801	2001/11/30
专利标题：Process for the crystallization of (r)- or (s)-lansoprazole 专利权人：TAKEDA PHARMACEUTICAL COMPANY LIMITED;

6. MX2013007588A	2013/8/9	MX20130007588	2013/6/27
专利标题：Orally disintegrating tablet. 专利权人：TAKEDA PHARMACEUTICAL COMPANY LIMITED; Provided is an orally disintegrating tablet obtained by tableting fine granules showing controlled release of lansoprazole and an additive which is capable of suppressing breakage of the fine granules during tableting and can control the release of lansoprazole for a long time and can maintain a therapeutically effective concentration for a prolonged time and shows superior disintegration property in the oral cavity. An orally disintegrating tablet containing (i) fine granules showing controlled...

7. PT2258351E	2013/7/29	PT20100178017T	2002/10/16
专利标题：Granules containing lansoprazole in large amount 专利权人：TAKEDA PHARMACEUTICAL COMPANY LIMITED;

8. AU2011350396A1	2013/7/11	AU20110350396	2011/12/26
专利标题：Orally disintegrating tablet 专利权人：TAKEDA PHARMACEUTICAL COMPANY LIMITED; Provided is an orally disintegrating tablet obtained by tableting fine granules showing controlled release of lansoprazole and an additive which is capable of suppressing breakage of the fine granules during tableting and can control the release of lansoprazole for a long time and can maintain a therapeutically effective concentration for a prolonged time and shows superior disintegration property in the oral cavity. An orally disintegrating tablet containing (i) fine granules showing controlled...

9. EP2258351B1	2013/6/19	EP20100178017	2002/10/16
专利标题：Granules containing lansoprazole in large amount 专利权人：TAKEDA PHARMACEUTICAL COMPANY LIMITED;

10. TW201304823A	2013/2/1	TW20110148775	2011/12/26
专利标题：Orally disintegrating tablet 专利权人：TAKEDA PHARMACEUTICAL COMPANY LIMITED; Provided is an orally disintegrating tablet obtained by tableting fine granules showing controlled release of lansoprazole and an additive which is capable of suppressing breakage of the fine granules during tableting and can control the release of lansoprazole for a long time and can maintain a therapeutically effective concentration for a prolonged time and shows superior disintegration property in the oral cavity. An orally disintegrating tablet containing (i) fine granules showing controlled...

下载范围

下载内容